JP2020510679A - ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 - Google Patents

ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 Download PDF

Info

Publication number
JP2020510679A
JP2020510679A JP2019548680A JP2019548680A JP2020510679A JP 2020510679 A JP2020510679 A JP 2020510679A JP 2019548680 A JP2019548680 A JP 2019548680A JP 2019548680 A JP2019548680 A JP 2019548680A JP 2020510679 A JP2020510679 A JP 2020510679A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
peo
mirabegron
composition according
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019548680A
Other languages
English (en)
Japanese (ja)
Inventor
スヨン キム
スヨン キム
ミンスー キム
ミンスー キム
ヘジン ソ
ヘジン ソ
シンジュン パク
シンジュン パク
Original Assignee
チョン クン ダン ファーマシューティカル コーポレイション
チョン クン ダン ファーマシューティカル コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by チョン クン ダン ファーマシューティカル コーポレイション, チョン クン ダン ファーマシューティカル コーポレイション filed Critical チョン クン ダン ファーマシューティカル コーポレイション
Publication of JP2020510679A publication Critical patent/JP2020510679A/ja
Priority to JP2021123899A priority Critical patent/JP2021185139A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2019548680A 2017-03-17 2018-03-15 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物 Pending JP2020510679A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021123899A JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0033944 2017-03-17
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
PCT/KR2018/003043 WO2018169325A1 (ko) 2017-03-17 2018-03-15 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021123899A Division JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Publications (1)

Publication Number Publication Date
JP2020510679A true JP2020510679A (ja) 2020-04-09

Family

ID=63522330

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019548680A Pending JP2020510679A (ja) 2017-03-17 2018-03-15 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物
JP2021123899A Pending JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021123899A Pending JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Country Status (4)

Country Link
JP (2) JP2020510679A (enExample)
KR (1) KR102051132B1 (enExample)
CN (1) CN110446490B (enExample)
WO (1) WO2018169325A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021069944A1 (en) * 2019-10-09 2021-04-15 Alvogen Korea Co., Ltd. Pharmaceutical composition comprising mirabegron and process for manufacturing the same
KR102546923B1 (ko) 2020-03-03 2023-06-26 동광제약 주식회사 미라베그론을 포함하는 제어 방출 제제
KR102794148B1 (ko) * 2021-08-18 2025-04-11 주식회사 삼양홀딩스 룩소리티닙의 경구용 정제 조성물 및 이의 제조 방법
EP4338729A1 (en) 2022-09-19 2024-03-20 Sanovel Ilac Sanayi Ve Ticaret A.S. A tablet comprising mirabegron
KR20240102908A (ko) * 2022-12-26 2024-07-03 주식회사 렉스팜텍 아픽사반을 포함하는 서방성 정제
EP4410279A1 (en) 2023-01-25 2024-08-07 Sanovel Ilac Sanayi Ve Ticaret A.S. A film tablet comprising mirabegron

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002501022A (ja) * 1998-01-22 2002-01-15 アボット・ラボラトリーズ 副作用の少ない持続放出性チアガビン製剤
JP2007516297A (ja) * 2003-12-23 2007-06-21 アルザ・コーポレーシヨン 制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
WO2010038690A1 (ja) * 2008-09-30 2010-04-08 アステラス製薬株式会社 放出制御医薬組成物
WO2011122523A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
JP2012136543A (ja) * 2006-08-25 2012-07-19 Purdue Pharma Lp オピオイド鎮痛薬を含む不正改変抵抗性経口医薬剤形

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003284700B2 (en) * 2002-11-07 2009-05-28 Astellas Pharma Inc. Remedy for overactive bladder comprising acetic acid anlide derivatives as the active ingredient
US20150031734A1 (en) * 2012-03-30 2015-01-29 Astellas Pharma Inc. Pharmaceutical composition containing mirabegron
KR20150045500A (ko) * 2012-08-31 2015-04-28 아스텔라스세이야쿠 가부시키가이샤 경구 투여용 의약 조성물
CN104288116A (zh) * 2014-09-05 2015-01-21 南京华威医药科技开发有限公司 一种米拉贝隆缓释片组合物
KR20170088783A (ko) * 2017-07-07 2017-08-02 지엘팜텍주식회사 미라베그론의 습식과립 조성물
EP3292864A1 (en) * 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002501022A (ja) * 1998-01-22 2002-01-15 アボット・ラボラトリーズ 副作用の少ない持続放出性チアガビン製剤
JP2007516297A (ja) * 2003-12-23 2007-06-21 アルザ・コーポレーシヨン 制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
JP2012136543A (ja) * 2006-08-25 2012-07-19 Purdue Pharma Lp オピオイド鎮痛薬を含む不正改変抵抗性経口医薬剤形
WO2010038690A1 (ja) * 2008-09-30 2010-04-08 アステラス製薬株式会社 放出制御医薬組成物
WO2011122523A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物

Also Published As

Publication number Publication date
JP2021185139A (ja) 2021-12-09
KR102051132B1 (ko) 2019-12-02
KR20180106185A (ko) 2018-10-01
WO2018169325A1 (ko) 2018-09-20
CN110446490A (zh) 2019-11-12
CN110446490B (zh) 2023-04-04

Similar Documents

Publication Publication Date Title
JP2020510679A (ja) ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物
KR102546742B1 (ko) 붕해가 개선된 경구용 고형 제제 조성물 및 이의 제조 방법
CN101983054B (zh) 含有咪达那新的口腔内迅速崩解性片剂
ES2622495T3 (es) Composición farmacéutica que contiene un antagonista de canales de calcio de dihidropiridina y método para su preparación
WO2009034541A9 (en) Controlled release pharmaceutical dosage forms of trimetazidine
AU2003282603A1 (en) Gastro-retentive levodopa delivery form
TW201311246A (zh) 使用有機酸助溶之４－甲基－３－［［４－（３－吡啶基）－２－嘧啶基］胺基］－ｎ－５－（４－甲基－１ｈ－咪唑－１－基）－３－（三氟甲基）苯基］苯甲醯胺之修飾釋放調配物
JP2021185139A5 (enExample)
WO2014104929A1 (ru) Фармацевтическая композиция для лечения вич-инфекции
CN100502877C (zh) 前列腺素i衍生物缓释制剂
HK1219889A1 (zh) 包含他达拉非和坦洛新的药物胶囊复合制剂
KR20150002453A (ko) 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
JP2017523149A (ja) エドキサバンの医薬組成物
KR20210096162A (ko) 의약 조성물
JP2024067030A (ja) ミラベグロン含有放出制御医薬組成物及びその製造方法
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
EP2409685A2 (en) Orally-disintegrating formulations of prasugrel
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
JP2022541948A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定した薬学的組成物
US20130259935A1 (en) Pharmaceutical compositions comprising glimepiride and polyethylene glycol castor oil
EP3023094B1 (en) Novel formulation of cilostazol
EP2409701B1 (en) Prasugrel granules with improved stability
JPWO2019221215A1 (ja) ルビプロストン含有粒子状医薬組成物
JP4696210B2 (ja) イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
JPWO2003075918A1 (ja) 塩酸ピルジカイニド含有錠剤（湿式）

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190906

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200720

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210329